Listen "Pramod John | VIVIO Health"
Episode Synopsis
Topics:
Specialty Drugs
Data Analytics
Net Acquisition Cost vs. Discount Pricing
Improving Health Outcomes
Specialty Drug Waste
Prior Authorization
Cost Savings
Misaligned Incentives
In this episode, Michael introduces you to Pramod John, CEO of VIVIO Health. Join us as we discuss how VIVIO Health, a specialty drug platform, utilizes data analytics and outcomes based models to help employers control their specialty drug spend.
Here’s a glance at what we discuss in this episode:
Pramod John’s software engineering and supply chain background and why he founded VIVIO Health
How drugs may be prescribed off-label and physicians prescribing patterns may be influenced by payments from drug manufacturers
How misaligned incentives have propelled our healthcare system into a cycle of complacency and how VIVIO Health seeks to break the cycle
Why its critical to focus on specialty drugs to contain costs in Rx spending
Why the current discount pricing model doesn’t work and leads to higher medical inflation year after year
Why a focus on specialty drug discount guarantees in PBM contracts may not be in the best interest of employers and lead to the purchase of higher cost drugs when lower cost drugs are available
Why the assumption that smaller companies like VIVIO Health can’t negotiate pricing competitive with Big PBM’s is false
Why a stamp of approval from the FDA may not mean a drug is safe or effective
The difference between effectiveness of a drug and efficacy and how many drugs on formularies are not impactful for improving clinical conditions they are designed to treat
The problems with the traditional prior authorization process and how VIVIO Health has changed the process to be a data driven approach to determining the optimal therapy for the specific patient
How VIVIO Health’s data collection process helps an employer to monitor if the drugs that are being prescribed are actually working and effective
The resistance from PBM’s to allow a vendor like VIVIO Health to carve out the administration, procurement and management of the specialty drug component
VIVIO Health’s platform and how they are improving the employee experience and helping reduce waste in prescribing practices and employer spend on specialty drugs by 30% to 50%
VIVIO Health’s...
Specialty Drugs
Data Analytics
Net Acquisition Cost vs. Discount Pricing
Improving Health Outcomes
Specialty Drug Waste
Prior Authorization
Cost Savings
Misaligned Incentives
In this episode, Michael introduces you to Pramod John, CEO of VIVIO Health. Join us as we discuss how VIVIO Health, a specialty drug platform, utilizes data analytics and outcomes based models to help employers control their specialty drug spend.
Here’s a glance at what we discuss in this episode:
Pramod John’s software engineering and supply chain background and why he founded VIVIO Health
How drugs may be prescribed off-label and physicians prescribing patterns may be influenced by payments from drug manufacturers
How misaligned incentives have propelled our healthcare system into a cycle of complacency and how VIVIO Health seeks to break the cycle
Why its critical to focus on specialty drugs to contain costs in Rx spending
Why the current discount pricing model doesn’t work and leads to higher medical inflation year after year
Why a focus on specialty drug discount guarantees in PBM contracts may not be in the best interest of employers and lead to the purchase of higher cost drugs when lower cost drugs are available
Why the assumption that smaller companies like VIVIO Health can’t negotiate pricing competitive with Big PBM’s is false
Why a stamp of approval from the FDA may not mean a drug is safe or effective
The difference between effectiveness of a drug and efficacy and how many drugs on formularies are not impactful for improving clinical conditions they are designed to treat
The problems with the traditional prior authorization process and how VIVIO Health has changed the process to be a data driven approach to determining the optimal therapy for the specific patient
How VIVIO Health’s data collection process helps an employer to monitor if the drugs that are being prescribed are actually working and effective
The resistance from PBM’s to allow a vendor like VIVIO Health to carve out the administration, procurement and management of the specialty drug component
VIVIO Health’s platform and how they are improving the employee experience and helping reduce waste in prescribing practices and employer spend on specialty drugs by 30% to 50%
VIVIO Health’s...
More episodes of the podcast Reconstructing Healthcare: Innovative Solutions For Employers To Lower Their Healthcare Costs
Colin Quinn | Included Health Communities
20/06/2022
Denise Shiffman | GroupWell
09/05/2022
Veeneta Lakhani | Vida Health
15/02/2022
Wally Gomaa | SimplePay Health
18/01/2022
Marshall Allen
12/07/2021
Dave Jacobs and David Greenberg | Homethrive
13/05/2021
Nate Murray | Crossover Health
14/04/2021
Christin Deacon | Amino
19/03/2021
Omar Dawood | Calm
10/03/2021